Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 19 September

Sophia Mavridis
September 19, 2023

Morning Bell 18 September

Sam Kanaan
September 18, 2023

Weekly Wrap 15 September

Grady Wulff
September 15, 2023

Morning Bell 15 September

Sam Kanaan
September 15, 2023

Morning Bell 14 September

Grady Wulff
September 14, 2023

Morning Bell 13 September

Grady Wulff
September 13, 2023

Morning Bell 12 September

Sam Kanaan
September 12, 2023

Morning Bell 11 September

Grady Wulff
September 11, 2023

Weekly Wrap 8 September

Grady Wulff
September 8, 2023

Morning Bell 7 September

Sam Kanaan
September 7, 2023

Morning Bell 6 September

Grady Wulff
September 6, 2023